Hawaii SCR 227: REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A MEDICINAL PSILOCYBIN AND PSILOCIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND PSILOCIN AND DEVELOP A LONG-TERM STRATEGIC PLAN TO ENSURE THE AVAILABILITY OF MEDICINAL PSILOCYBIN AND PSILOCIN OR PSILOCYBIN-BASED AND PSILOCIN-BASED PRODUCTS THAT ARE SAFE, ACCESSIBLE, AND AFFORDABLE FOR ELIGIBLE ADULT PATIENTS.

Status: Referred to HTH. (as of 2022-03-16)

State: Hawaii · Session: 2022 Regular Session · Bill: SCR 227

Subjects: Department of Health, Medical Psilocybin and Psilocin Working Group

Sponsors: CHANG, GABBARD, SAN BUENAVENTURA, Ihara, Misalucha

View Hawaii SCR 227 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.